Mette F. Olsen, MSc, PhD

Poster(s):

• (6) Decline in HbA1c during the First Year on Elexacaftor/Tezacaftor/Ivacaftor in the Danish CF Population
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (126) Change in Pulmonary Function after Introduction of Elexacaftor/tezacaftor/ivacaftor: Results from the National CF-cohort in Denmark
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (253) Change in liver biomarkers after introduction of elexacaftor/tezacaftor/ivacaftor: Results from a 12-month follow-up study in the national CF-cohort in Denmark
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (484) Change in pulmonary infections 12 months after elexacaftor/tezacaftor/ivacaftor introduction: Results from the Danish National Cystic Fibrosis Cohort
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET